Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
XORTX Therapeutics Inc. (XRTX) had Return on Equity of -30.71% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.69M |
|
-- |
|
-- |
|
$1.69M |
|
$-1.69M |
|
$-0.00M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.67M |
|
1.62M |
|
1.62M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$2.44M |
|
-- |
|
$3.75M |
|
$6.18M |
|
$0.68M |
|
-- |
|
-- |
|
$0.68M |
|
$5.50M |
|
$2.96M |
|
$5.50M |
|
1.73M |
|
| Cash Flow Statement Financials | |
$-3.77M |
|
$-0.15M |
|
$4.05M |
|
$0.86M |
|
$0.99M |
|
$0.13M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-30.71% |
-57.17% |
|
-27.34% |
|
-30.71% |
|
$3.18 |
|
$-2.33 |
|
$-2.33 |
|